Indu Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Indu Drugs Private Limited

Indu Drugs Private Limited, a active private limited company, was established on 04 April 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85191TG2012PTC080169. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.40 Cr and a paid-up capital of ₹4.39 Cr.

It upholds a compliant status. Employing 64 professional, Its leadership includes Sai Kumar Talasila (Whole-Time Director), Venkateswara Rao Talasila (Whole-Time Director), Talasila Hari Prasada Rao (Managing Director). Past directors included Rajeswari Talasila, Sai Kumar Talasila, Venkateswara Rao Talasila. It holds ₹4.00 Cr open charges and ₹2.90 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-5-35/278 & 279, Prashanthi Nagar Ida, Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85191TG2012PTC080169

  • Registration Number

    080169

  • Incorporation Date

    04 April 2012

  • Authorized Capital

    ₹4.40 Cr

  • Paid-Up Capital

    ₹4.39 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.40 Cr
  • Paid Up Capital ₹ 4.39 Cr
  • Company Age 13 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 Cr
  • Satisfied Charges ₹ 2.90 Cr
  • Revenue Growth **** 42.44%
  • Profit Growth **** 121.71%
  • Ebitda **** 34.72%
  • Net Worth 5.26%
  • Total Assets **** 9.67%
Company report

Indu Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Indu Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Indu Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sai Kumar Talasila Whole-Time Director 23 Nov 2016 Current
Venkateswara Rao Talasila Whole-Time Director 09 Nov 2013 Current
Talasila Hari Prasada Rao Managing Director 04 Apr 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2018 Past
Pramod Abcsdd Director 01 Apr 2018 Past
Pramod Abcsdd Director 01 Apr 2018 Past
Pramod Abcsdd Additional Director 01 Apr 2018 Past
Pramod Abcsdd Director 09 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indu Drugs.

Indu Drugs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 42.44% increase. The company also saw a substantial improvement in profitability, with a 121.71% increase in profit. The company's net worth moved up by a moderate rise of 5.26%.

Indu Drugs revenue growth over time
Indu Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.44%
*******
*******
*******
*******
Revenue from Operations
*******
 41.86%
*******
*******
*******
*******
Total Assets
*******
 9.67%
*******
*******
*******
*******
Profit or Loss
*******
 121.71%
*******
*******
*******
*******
Net Worth
*******
 5.26%
*******
*******
*******
*******
EBITDA
*******
 34.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indu Drugs?

In 2024, Indu Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹40,000,000.00

Satisfied Charges

₹29,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4.00 Cr
Latest Charge Details
Date Lender Amount Status
15 Jul 2023 Hdfc Bank Limited ₹4.00 Cr Open
26 Dec 2018 Axis Bank Limited ₹5.00 M Satisfied
01 Oct 2015 Canara Bank ₹1.40 Cr Satisfied
05 Dec 2012 State Bank Of India ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Indu Drugs?

Indu Drugs has a workforce of 64 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indu Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indu Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Indu Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Indu Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 4.00 Cr registered on 15 Jul 2023 with Charge ID 100753475 was modified on 18 Jul 2023. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 4.00 Cr with Charge ID 100753475 was registered on 15 Jul 2023. was recorded as a recent event.

  • Charges

    A charge registered on 01 Oct 2015 via Charge ID 10595585 with Canara Bank was fully satisfied on 18 Mar 2023. was recorded as a recent event.

  • Charges

    A charge registered on 26 Dec 2018 via Charge ID 100243343 with Axis Bank Limited was fully satisfied on 21 Jan 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Indu Drugs Private Limited?

The CIN of Indu Drugs Private Limited is U85191TG2012PTC080169.

Where is Indu Drugs Private Limited headquartered?

Indu Drugs Private Limited is headquartered at 5-5-35/278 & 279, Prashanthi Nagar Ida, Kukatpally, Hyderabad, Telangana, 500072.

When was Indu Drugs Private Limited incorporated?

Indu Drugs Private Limited was incorporated on 04 April 2012.

Who are the current directors of Indu Drugs Private Limited?

The current directors of Indu Drugs Private Limited are

What is the primary industry of Indu Drugs Private Limited?

The primary industry of Indu Drugs Private Limited is Manufacturing.

Is Indu Drugs Private Limited a listed company?

Indu Drugs Private Limited is unlisted.

What is the capital structure of Indu Drugs Private Limited?

The authorized capital of Indu Drugs Private Limited is ₹4.40 Cr, and the paid-up capital is ₹4.39 Cr.

What is the compliance status of Indu Drugs Private Limited?

The compliance status of Indu Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available